• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immun Inflamm Dis . Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, Ch

tetano

Editor, Senior Moderator
Immun Inflamm Dis


. 2020 Aug 28.
doi: 10.1002/iid3.343. Online ahead of print.
Disease progression patterns and risk factors associated with mortality in deceased patients with COVID-19 in Hubei Province, China


Liang Chen[SUP] 1 [/SUP], Song Liu[SUP] 2 [/SUP], Juncai Tian[SUP] 3 [/SUP], Haisong Pan[SUP] 1 [/SUP], Yu Liu[SUP] 1 [/SUP], Jun Hu[SUP] 1 [/SUP], Maoren Wang[SUP] 4 [/SUP], Xuewen Hou[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Detailed descriptions of the patterns of disease progression of deceased coronavirus disease 2019 (COVID-19) patients have not been well explored.
Objectives: This study sought to explore disease progression patterns and risk factors associated with mortality of deceased patients with COVID-19.
Materials and methods: Epidemiological, clinical, laboratory, and imaging data (from 15 January to 26 March 2020) of laboratory-confirmed COVID-19 patients were collected retrospectively from two hospitals, Hubei province, China. Disease progression patterns of patients were analyzed based on laboratory data, radiological findings, and Sequential Organ Failure Assessment (SOFA) score. Risk factors associated with death were analyzed.
Results: A total of 792 patients were enrolled in this study, of whom 68 died and 724 survived. Complications during hospitalization, such as sepsis, severe acute respiratory distress syndrome, acute cardiac injury, and acute kidney injury, were markedly more frequent in deceased patients than in surviving patients. Deceased patients presented progressive deterioration pattern in laboratory variables, chest computed tomography evaluation, and SOFA score, while surviving patients presented initial deterioration to peak level involvement followed by improvement pattern over time. Days 10 to 14 after illness onset was a critical stage of disease course. Older age, number of preexisting comorbidities ≥2, and SOFA score were independently associated with death for COVID-19.
Conclusions: Multiorgan dysfunction was common in deceased COVID-19 patients. Deceased patients presented progressive deterioration pattern, while surviving patients presented a relatively stable pattern during disease progression. Older age, number of preexisting comorbidities ≥2, and SOFA score were independent risk factors for death for COVID-19.

Keywords: COVID-19; SARS-CoV-2; SOFA score; disease progression pattern.
 
Back
Top Bottom